Drug Screening Market by Product, Sample Type, End User - Global Forecast 2025-2030- Product Image

Sale

Drug Screening Market by Product, Sample Type, End User - Global Forecast 2025-2030

Report
198 Pages
October 2024
Region: Global
360iResearch™
ID: 5674413

UP TO €688EUR$697USD£574GBP OFF until Dec 31^st 2024

The Drug Screening Market grew from USD 8.66 billion in 2023 to USD 9.89 billion in 2024. It is expected to continue growing at a CAGR of 14.42%, reaching USD 22.25 billion by 2030.

The scope and definition of drug screening encompass a range of procedures used to detect the presence of illicit substances or prescribed medications in an individual's system. This includes applications in various settings such as workplaces, sports organizations, and healthcare facilities, making drug screening vital for ensuring safety, compliance, and legal adherence. The necessity of drug screening has grown due to increased substance abuse, regulatory mandates, and the need for organizations to maintain productive and safe environments. This market finds end-use across sectors such as law enforcement, corporate sectors, rehabilitation centers, and hospitals. Key influencing growth factors include heightened awareness regarding substance abuse, technological advancements in testing methods, and the increased adoption of point-of-care testing. The rise in government initiatives and the adoption of workplace drug policies are driving opportunities, with a notable inclination towards developing rapid, cost-effective, and more accurate screening tests. Emerging trends such as the integration of artificial intelligence and machine learning in testing processes present potential growth avenues. However, the major limitations and challenges affecting market growth include privacy concerns, regulatory constraints, and the high cost of advanced testing equipment. Additionally, false positives or negatives can pose reliability issues, thereby affecting market perception. Despite these challenges, areas ripe for innovation include the development of multi-drug screening panels, non-invasive testing methodologies, and the expansion of portable testing devices that offer quicker results. Engaging in collaborative research with biotech firms and investing in AI-enhanced predictive analytics for better test accuracy can also drive business growth. Overall, the drug screening market is poised for extensive growth yet requires strategic navigation of its challenges to unlock its potential fully.

Understanding Market Dynamics in the Drug Screening Market

The Drug Screening Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Surge in both recreational and prescription drug misuse globally
- Increased safety and compliance in workplaces
- Regulations by governments and organizational policies mandating drug testing
Market Restraints
- Possibility of manipulation of drug screening results
Market Opportunities
- Development of innovative drug screening technologies and kits
- Growing demand for mobile and on-site drug testing services
Market Challenges
- Lack of standard regulatory framework for drug screening across economies

Exploring Porter’s Five Forces for the Drug Screening Market

Porter’s Five Forces framework further strengthens the insights of the Drug Screening Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Drug Screening Market

External macro-environmental factors deeply influence the performance of the Drug Screening Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Drug Screening Market

The Drug Screening Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Drug Screening Market

The Drug Screening Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Drug Screening Market

The Drug Screening Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Screening Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AccuSourceHR, Inc., ACM Global Laboratories, Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Clinical Reference Laboratory, Inc., Cordant Health Solutions, Danaher Corporation, Drägerwerk AG & Co. KGaA, F. Hoffmann-La Roche Ltd., Intoximeters, Inc., Laboratory Corporation of America Holdings, Lifeloc Technologies, Inc., Merck KGaA, Omega Laboratories, Inc. by Juno Pharmaceuticals Corp., OraSure Technologies, Inc., Pfizer Inc., Premier Biotech, LLC, Psychemedics Corporation, Quest Diagnostics Incorporated, Sartorius AG, Securetec Detektions-Systeme AG, Shimadzu Corporation, Siemens AG, Thermo Fisher Scientific Inc., and United States Drug Testing Laboratories, Inc..

Market Segmentation & Coverage

This research report categorizes the Drug Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Consumables
  - Assay Kits
  - Calibrators & Controls
  - Sample Collection Tubes
- Instruments
  - Analytical Instruments
    - Breathalyzers
      - Fuel-Cell Breathalyzers
      - Semiconductor Breathalyzers
    - Chromatography Instruments
    - Immunoassay Analyzers
  - Rapid Testing Devices
    - Oral Fluid Testing Devices
    - Urine Testing Devices
      - Dip Cards
      - Drug Testing Cassettes
      - Drug Testing Cups
- Services
Sample Type
- Breath Samples
- Hair Samples
- Oral Fluid Samples
- Urine Samples
End User
- Criminal Justice Systems & Law Enforcement Agencies
- Drug Testing Laboratories
- Drug Treatment Centers
- Hospitals
- Individual Users
- Pain Management Centers
- Schools & Colleges
- Workplaces

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Surge in both recreational and prescription drug misuse globally
5.1.1.2. Increased safety and compliance in workplaces
5.1.1.3. Regulations by governments and organizational policies mandating drug testing
5.1.2. Restraints
5.1.2.1. Possibility of manipulation of drug screening results
5.1.3. Opportunities
5.1.3.1. Development of innovative drug screening technologies and kits
5.1.3.2. Growing demand for mobile and on-site drug testing services
5.1.4. Challenges
5.1.4.1. Lack of standard regulatory framework for drug screening across economies
5.2. Market Segmentation Analysis
5.2.1. Product: Proliferating utilization of oral fluid testing devices providing non-invasive quick results
5.2.2. End User: Significant utilization of the drug screening in the drug treatment centers
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Drug Screening Market, by Product

6.1. Introduction
6.2. Consumables
6.2.1. Assay Kits
6.2.2. Calibrators & Controls
6.2.3. Sample Collection Tubes
6.3. Instruments
6.3.1. Analytical Instruments
6.3.1.1. Breathalyzers
6.3.1.1.1. Fuel-Cell Breathalyzers
6.3.1.1.2. Semiconductor Breathalyzers
6.3.1.2. Chromatography Instruments
6.3.1.3. Immunoassay Analyzers
6.3.2. Rapid Testing Devices
6.3.2.1. Oral Fluid Testing Devices
6.3.2.2. Urine Testing Devices
6.3.2.2.1. Dip Cards
6.3.2.2.2. Drug Testing Cassettes
6.3.2.2.3. Drug Testing Cups
6.4. Services

7. Drug Screening Market, by Sample Type

7.1. Introduction
7.2. Breath Samples
7.3. Hair Samples
7.4. Oral Fluid Samples
7.5. Urine Samples

8. Drug Screening Market, by End User

8.1. Introduction
8.2. Criminal Justice Systems & Law Enforcement Agencies
8.3. Drug Testing Laboratories
8.4. Drug Treatment Centers
8.5. Hospitals
8.6. Individual Users
8.7. Pain Management Centers
8.8. Schools & Colleges
8.9. Workplaces

9. Americas Drug Screening Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Drug Screening Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Drug Screening Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Innovative Partnership Launches Virtual Drug Screening Platform
12.3.2. Launch of Accurate Background’s Advanced Drug and Health Screening Services
12.3.3. bioXcelerate Revolutionizes Drug Discovery with AI-Powered Screening Tool
12.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. DRUG SCREENING MARKET RESEARCH PROCESS
FIGURE 2. DRUG SCREENING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DRUG SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL DRUG SCREENING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL DRUG SCREENING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES DRUG SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES DRUG SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. DRUG SCREENING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. DRUG SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. DRUG SCREENING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DRUG SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. DRUG SCREENING MARKET DYNAMICS
TABLE 7. GLOBAL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DRUG SCREENING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG SCREENING MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DRUG SCREENING MARKET SIZE, BY CALIBRATORS & CONTROLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG SCREENING MARKET SIZE, BY SAMPLE COLLECTION TUBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DRUG SCREENING MARKET SIZE, BY FUEL-CELL BREATHALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG SCREENING MARKET SIZE, BY SEMICONDUCTOR BREATHALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DRUG SCREENING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG SCREENING MARKET SIZE, BY ORAL FLUID TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG SCREENING MARKET SIZE, BY DIP CARDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TESTING CASSETTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TESTING CUPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG SCREENING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG SCREENING MARKET SIZE, BY BREATH SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DRUG SCREENING MARKET SIZE, BY HAIR SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG SCREENING MARKET SIZE, BY ORAL FLUID SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DRUG SCREENING MARKET SIZE, BY URINE SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DRUG SCREENING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TESTING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TREATMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DRUG SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DRUG SCREENING MARKET SIZE, BY INDIVIDUAL USERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DRUG SCREENING MARKET SIZE, BY PAIN MANAGEMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DRUG SCREENING MARKET SIZE, BY SCHOOLS & COLLEGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DRUG SCREENING MARKET SIZE, BY WORKPLACES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. CANADA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. CANADA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 76. CANADA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 77. CANADA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 78. CANADA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 79. CANADA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 80. CANADA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 81. CANADA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 82. CANADA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. MEXICO DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. MEXICO DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 85. MEXICO DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 86. MEXICO DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 87. MEXICO DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 88. MEXICO DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 89. MEXICO DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 90. MEXICO DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 91. MEXICO DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES DRUG SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 112. AUSTRALIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. AUSTRALIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. CHINA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. CHINA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 123. CHINA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 124. CHINA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 125. CHINA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 126. CHINA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 127. CHINA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 128. CHINA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 129. CHINA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. INDIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. INDIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 132. INDIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 133. INDIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 134. INDIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 135. INDIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 136. INDIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 137. INDIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 138. INDIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. INDONESIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. INDONESIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 141. INDONESIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 142. INDONESIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 143. INDONESIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 144. INDONESIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 145. INDONESIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 146. INDONESIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 147. INDONESIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. JAPAN DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. JAPAN DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 150. JAPAN DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 151. JAPAN DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 152. JAPAN DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 153. JAPAN DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 154. JAPAN DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 155. JAPAN DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 156. JAPAN DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. MALAYSIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. MALAYSIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 159. MALAYSIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 160. MALAYSIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 161. MALAYSIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 162. MALAYSIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 163. MALAYSIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 164. MALAYSIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 165. MALAYSIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. PHILIPPINES DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. PHILIPPINES DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 168. PHILIPPINES DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 169. PHILIPPINES DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 170. PHILIPPINES DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 171. PHILIPPINES DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 172. PHILIPPINES DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 173. PHILIPPINES DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 174. PHILIPPINES DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. SINGAPORE DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. SINGAPORE DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 177. SINGAPORE DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 178. SINGAPORE DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 179. SINGAPORE DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 180. SINGAPORE DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 181. SINGAPORE DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 182. SINGAPORE DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 183. SINGAPORE DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 186. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 187. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 188. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 189. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 190. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 191. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 192. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. TAIWAN DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 194. TAIWAN DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 195. TAIWAN DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 196. TAIWAN DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 197. TAIWAN DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 198. TAIWAN DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 199. TAIWAN DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 200. TAIWAN DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 201. TAIWAN DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. THAILAND DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 203. THAILAND DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 204. THAILAND DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 205. THAILAND DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 206. THAILAND DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 207. THAILAND DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 208. THAILAND DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 209. THAILAND DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 210. THAILAND DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. VIETNAM DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 212. VIETNAM DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 213. VIETNAM DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 214. VIETNAM DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 215. VIETNAM DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 216. VIETNAM DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 217. VIETNAM DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 218. VIETNAM DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 219. VIETNAM DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 230. DENMARK DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 231. DENMARK DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 232. DENMARK DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 233. DENMARK DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 234. DENMARK DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 235. DENMARK DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 236. DENMARK DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 237. DENMARK DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 238. DENMARK DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. EGYPT DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 240. EGYPT DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 241. EGYPT DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 242. EGYPT DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 243. EGYPT DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 244. EGYPT DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 245. EGYPT DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 246. EGYPT DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 247. EGYPT DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. FINLAND DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 249. FINLAND DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 250. FINLAND DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 251. FINLAND DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 252. FINLAND DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 253. FINLAND DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 254. FINLAND DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 255. FINLAND DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 256. FINLAND DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. FRANCE DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 258. FRANCE DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 259. FRANCE DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 260. FRANCE DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 261. FRANCE DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 262. FRANCE DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 263. FRANCE DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 264. FRANCE DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 265. FRANCE DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. GERMANY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 267. GERMANY DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 268. GERMANY DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 269. GERMANY DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 270. GERMANY DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 271. GERMANY DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 272. GERMANY DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 273. GERMANY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 274. GERMANY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. ISRAEL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 276. ISRAEL DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 277. ISRAEL DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 278. ISRAEL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 279. ISRAEL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 280. ISRAEL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 281. ISRAEL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 282. ISRAEL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 283. ISRAEL DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. ITALY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 285. ITALY DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 286. ITALY DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 287. ITALY DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 288. ITALY DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 289. ITALY DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 290. ITALY DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 291. ITALY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 292. ITALY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. NETHERLANDS DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 294. NETHERLANDS DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 295. NETHERLANDS DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 296. NETHERLANDS DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 297. NETHERLANDS DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 298. NETHERLANDS DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 299. NETHERLANDS DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 300. NETHERLANDS DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 301. NETHERLANDS DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. NIGERIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 303. NIGERIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 304. NIGERIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 305. NIGERIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 306. NIGERIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 307. NIGERIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 308. NIGERIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 309. NIGERIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 310. NIGERIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. NORWAY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 312. NORWAY DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 313. NORWAY DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 314. NORWAY DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 315. NORWAY DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 316. NORWAY DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 317. NORWAY DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 318. NORWAY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 319. NORWAY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. POLAND DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 321. POLAND DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 322. POLAND DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 323. POLAND DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 324. POLAND DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 325. POLAND DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 326. POLAND DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 327. POLAND DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 328. POLAND DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 329. QATAR DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 330. QATAR DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 331. QATAR DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 332. QATAR DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 333. QATAR DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 334. QATAR DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 335. QATAR DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 336. QATAR DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 337. QATAR DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 338. RUSSIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 339. RUSSIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 340. RUSSIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 341. RUSSIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 342. RUSSIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 343. RUSSIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 344. RUSSIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 345. RUSSIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 346. RUSSIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 347. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 348. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 349. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 350. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 351. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 352. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 353. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 354. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 355. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 356. SOUTH AFRICA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 357. SOUTH AFRICA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 358. SOUTH AFRICA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 359. SOUTH AFRICA DRUG SCREENING MARKET SI

Companies Mentioned

The leading players in the Drug Screening market, which are profiled in this report, include:

Abbott Laboratories
AccuSourceHR, Inc.
ACM Global Laboratories
Alfa Scientific Designs, Inc.
Bio-Rad Laboratories, Inc.
Clinical Reference Laboratory, Inc.
Cordant Health Solutions
Danaher Corporation
Drägerwerk AG & Co. KGaA
F. Hoffmann-La Roche Ltd.
Intoximeters, Inc.
Laboratory Corporation of America Holdings
Lifeloc Technologies, Inc.
Merck KGaA
Omega Laboratories, Inc. by Juno Pharmaceuticals Corp.
OraSure Technologies, Inc.
Pfizer Inc.
Premier Biotech, LLC
Psychemedics Corporation
Quest Diagnostics Incorporated
Sartorius AG
Securetec Detektions-Systeme AG
Shimadzu Corporation
Siemens AG
Thermo Fisher Scientific Inc.
United States Drug Testing Laboratories, Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	198
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 9.89 Billion
Forecasted Market Value ( USD ) by 2030	$ 22.25 Billion
Compound Annual Growth Rate	14.4%
Regions Covered	Global
No. of Companies Mentioned	27

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3502EUR$3,545USD£2,918GBP €3891EUR$3,939USD£3,243GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6195EUR$6,272USD£5,163GBP €6883EUR$6,969USD£5,737GBP

Understanding Market Dynamics in the Drug Screening Market

Exploring Porter’s Five Forces for the Drug Screening Market

Applying PESTLE Analysis to the Drug Screening Market

Analyzing Market Share in the Drug Screening Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Drug Screening Market

Strategic Recommendations for Success in the Drug Screening Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Drug Screening Market by Product (Rapid Testing (Urine, Oral), Analytical (Breathalyzer, Immunoassay, Chromatography)), Sample (Urine, Breath, Hair), Drug (Alcohol, Cannabis, Opioids), End User (Workplace, Hospital, Law) - Forecast to 2029

Drug Screening Market Size, Share & Trends Analysis Report by Product Type (Instruments, Rapid Testing Devices), Sample Type (Urine Sample, Breath Sample), End-use, Region, and Segment Forecasts, 2024-2030

Toxicology Drug Screening Market by Product, Testing, Application - Global Forecast 2025-2030

Drug Screening Market Size and Forecasts 2020-2030: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product; Technology; Application; and End-User

Drug Screening Market Report by Product and Service, Sample Type, End User, and Region 2024-2032